[275 Pages Report] Global glandular ingredients demand is anticipated to be valued at US$ 105.83 Billion in 2022, forecast to grow at a CAGR of 6.9% to be valued at US$ 206.25 Billion from 2022 to 2032. Glandular ingredients are dietary supplements that contain nutritional sources that support the function of specific glands. Lyophilization of certain glands derived from animals is used to process glandular ingredients.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 100 Billion |
| Expected Market Value (2022) | US$ 105.83 Billion |
| Anticipated Forecast Value (2032) | US$ 206.25 Billion |
| Projected Growth Rate (2022 to 2032) | 6.9% CAGR |
Glandular ingredients can be prepared as a powder or as an extract. The glandular ingredients are typically extracted from range-fed bovine (cow), porcine (pig), or ovine (sheep) that have been disease-freely inspected by the government.
Most manufacturers believe that glandular from animals raised in New Zealand and Australia are the best glandular ingredients for human consumption because the animal husbandry regulations in these countries are the strictest. Organic glandular ingredients are those that have been freeze-dried without the use of hormones or antibiotics.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Many health professionals recommend glandular ingredients as part of the diet for people who don't get enough of these nutrients from their regular diet. This can be consumed in either freeze-dried powder or encapsulated form. Professionals' recommendation of glandular ingredient consumption as part of a comprehensive nutritional program is based on various studies.
The increasing demand for functional foods and nutraceuticals in various industries is driving the growth of this market. Rising income levels, a growing population, and technological advancements are some of the other major factors driving the growth of this market.
The shift in consumer attention from regular food consumption to alternative remedies for obtaining specific nutrients has promoted the use of glandular ingredients as a supplement, either alone or in combination with others. These glandular ingredients are in high demand by pharmaceutical companies because glandular capsules are being prescribed clinically for a variety of disorders.
The global glandular ingredients market is expected to face challenges due to the scarcity and high cost of raw materials, as well as high production costs.
Principal Consultant
During the forecast period, Europe's glandular ingredients market will grow at a CAGR of 5%. Europe is expected to be the world's second-largest market. The increasing consumption of pharmaceutical products and functional food items by health-conscious consumers can be attributed to the high demand for glandular ingredients in this region.
Around 40% of Europeans regularly supplement their diets, and it is expected that this trend of consuming dietary supplements will continue. The demand for glandular ingredients will rise as a result. Within Europe, the United Kingdom and Germany are expected to experience rapid market growth. For mainstream products, the United Kingdom has well-established brands.
Specialty ingredients companies, such as ABF Ingredients and DuPont, are attempting to capitalize on the country's growing consumer demand for healthier foods. In order to expand their glandular ingredients market growth, large specialty ingredient companies in Germany are expected to continue targeting niche suppliers with a proven track record of innovation.
The North American region consumes the most glandular ingredients. This region's high demand for these products can be attributed to the large population and the growing trend of consuming functional foods.
The North America Specialty Food Ingredients Market is divided into three regions: the United States, Canada, and the rest of North America. With a large percentage of the population suffering from obesity and diabetic risks, there is a demand in the United States for functional foods and specialty food ingredients.
Through glandular ingredients, processing industries in this region are keen on obtaining the best formulation to present the best food product to the consumer.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Organic glandular ingredient is a glandular ingredient obtained from animals via organic farming. In general, the ingredients are used as functional food additives in the pharmaceutical, nutraceuticals, and animal feed industries. As a result, the organic glandular ingredient segment is expected to experience high demand in the market over the forecast period.
Another major consumer of glandular ingredients is the sports nutrition industry. The growing number of athletes and bodybuilders seeking to improve their performance through natural means drives the demand for these products in this sector. Over the next few years, the sports nutrition segment is expected to propel market growth.
Laboratorio Opoterapico Argentino S.A., Agri-lab Co-Products Ltd., Allergy Research Group LLC, American Biologics, Pure Natura ehf., Fallwood Corporation, American Laboratories, Inc., Food Science Corporation, and MBi Nutraceuticals are some of the leading players in the global glandular ingredients market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.9% from 2022 to 2032 |
| Market Value in 2022 | US$ 105.83 Billion |
| Market Value in 2032 | US$ 206.25 Billion |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global Glandular Ingredients market to expand at a 6.9% value CAGR by 2032
North America is expected to be the most opportunistic Glandular Ingredients market.
Laboratorio Opoterapico Argentino S.A., Agri-lab Co-Products Ltd., Allergy Research Group LLC, American Biologics, Pure Natura ehf., Fallwood Corporation, American Laboratories, Inc., Food Science Corporation, and MBi Nutraceuticals are some prominent Glandular Ingredients manufacturers.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Nature
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Nature, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Nature, 2022-2032
5.3.1. Organic
5.3.2. Conventional
5.4. Y-o-Y Growth Trend Analysis By Nature, 2017-2021
5.5. Absolute $ Opportunity Analysis By Nature, 2022-2032
6. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Form, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Form, 2022-2032
6.3.1. Powder
6.3.2. Extract
6.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021
6.5. Absolute $ Opportunity Analysis By Form, 2022-2032
7. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Source
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Source, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Source, 2022-2032
7.3.1. Bovine
7.3.2. Porcine
7.3.3. Ovine
7.4. Y-o-Y Growth Trend Analysis By Source, 2017-2021
7.5. Absolute $ Opportunity Analysis By Source, 2022-2032
8. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Type, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Type, 2022-2032
8.3.1. Adrenal
8.3.2. Cortex
8.3.3. Medulla
8.3.4. Pancreas
8.3.5. Bone Marrow
8.3.6. Hypothalamus
8.3.7. Immuno-gland
8.3.8. Kidney
8.3.9. Liver
8.3.10. Thyroid
8.3.11. Thymus
8.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
8.5. Absolute $ Opportunity Analysis By Type, 2022-2032
9. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By End Use
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End Use, 2017-2021
9.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End Use, 2022-2032
9.3.1. Dietary Supplements
9.3.2. Nutraceuticals
9.3.3. Pharmaceuticals
9.3.4. Sports Nutrition
9.3.5. Animal Feed
9.4. Y-o-Y Growth Trend Analysis By End Use, 2017-2021
9.5. Absolute $ Opportunity Analysis By End Use, 2022-2032
10. Global Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021
10.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia & Pacific
10.3.6. MEA
10.4. Market Attractiveness Analysis By Region
11. North America Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. U.S.
11.2.1.2. Canada
11.2.2. By Nature
11.2.3. By Form
11.2.4. By Source
11.2.5. By Type
11.2.6. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Nature
11.3.3. By Form
11.3.4. By Source
11.3.5. By Type
11.3.6. By End Use
11.4. Key Takeaways
12. Latin America Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Mexico
12.2.1.2. Brazil
12.2.1.3. Rest of Latin America
12.2.2. By Nature
12.2.3. By Form
12.2.4. By Source
12.2.5. By Type
12.2.6. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Nature
12.3.3. By Form
12.3.4. By Source
12.3.5. By Type
12.3.6. By End Use
12.4. Key Takeaways
13. Europe Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. Italy
13.2.1.3. France
13.2.1.4. U.K.
13.2.1.5. Spain
13.2.1.6. BENELUX
13.2.1.7. Russia
13.2.1.8. Rest of Europe
13.2.2. By Nature
13.2.3. By Form
13.2.4. By Source
13.2.5. By Type
13.2.6. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Nature
13.3.3. By Form
13.3.4. By Source
13.3.5. By Type
13.3.6. By End Use
13.4. Key Takeaways
14. East Asia Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Nature
14.2.3. By Form
14.2.4. By Source
14.2.5. By Type
14.2.6. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Nature
14.3.3. By Form
14.3.4. By Source
14.3.5. By Type
14.3.6. By End Use
14.4. Key Takeaways
15. South Asia & Pacific Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. India
15.2.1.2. ASEAN
15.2.1.3. Australia and New Zealand
15.2.1.4. Rest of South Asia & Pacific
15.2.2. By Nature
15.2.3. By Form
15.2.4. By Source
15.2.5. By Type
15.2.6. By End Use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Nature
15.3.3. By Form
15.3.4. By Source
15.3.5. By Type
15.3.6. By End Use
15.4. Key Takeaways
16. MEA Glandular Ingredients Market Analysis 2017-2021 and Forecast 2022-2032, By Country
16.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
16.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. Turkey
16.2.1.3. South Africa
16.2.1.4. Rest of MEA
16.2.2. By Nature
16.2.3. By Form
16.2.4. By Source
16.2.5. By Type
16.2.6. By End Use
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Nature
16.3.3. By Form
16.3.4. By Source
16.3.5. By Type
16.3.6. By End Use
16.4. Key Takeaways
17. Key Countries Glandular Ingredients Market Analysis
17.1. U.S.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2021
17.1.2.1. By Nature
17.1.2.2. By Form
17.1.2.3. By Source
17.1.2.4. By Type
17.1.2.5. By End Use
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2021
17.2.2.1. By Nature
17.2.2.2. By Form
17.2.2.3. By Source
17.2.2.4. By Type
17.2.2.5. By End Use
17.3. Mexico
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2021
17.3.2.1. By Nature
17.3.2.2. By Form
17.3.2.3. By Source
17.3.2.4. By Type
17.3.2.5. By End Use
17.4. Brazil
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2021
17.4.2.1. By Nature
17.4.2.2. By Form
17.4.2.3. By Source
17.4.2.4. By Type
17.4.2.5. By End Use
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2021
17.5.2.1. By Nature
17.5.2.2. By Form
17.5.2.3. By Source
17.5.2.4. By Type
17.5.2.5. By End Use
17.6. Italy
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2021
17.6.2.1. By Nature
17.6.2.2. By Form
17.6.2.3. By Source
17.6.2.4. By Type
17.6.2.5. By End Use
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2021
17.7.2.1. By Nature
17.7.2.2. By Form
17.7.2.3. By Source
17.7.2.4. By Type
17.7.2.5. By End Use
17.8. U.K.
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2021
17.8.2.1. By Nature
17.8.2.2. By Form
17.8.2.3. By Source
17.8.2.4. By Type
17.8.2.5. By End Use
17.9. Spain
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2021
17.9.2.1. By Nature
17.9.2.2. By Form
17.9.2.3. By Source
17.9.2.4. By Type
17.9.2.5. By End Use
17.10. BENELUX
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2021
17.10.2.1. By Nature
17.10.2.2. By Form
17.10.2.3. By Source
17.10.2.4. By Type
17.10.2.5. By End Use
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2021
17.11.2.1. By Nature
17.11.2.2. By Form
17.11.2.3. By Source
17.11.2.4. By Type
17.11.2.5. By End Use
17.12. China
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2021
17.12.2.1. By Nature
17.12.2.2. By Form
17.12.2.3. By Source
17.12.2.4. By Type
17.12.2.5. By End Use
17.13. Japan
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2021
17.13.2.1. By Nature
17.13.2.2. By Form
17.13.2.3. By Source
17.13.2.4. By Type
17.13.2.5. By End Use
17.14. South Korea
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2021
17.14.2.1. By Nature
17.14.2.2. By Form
17.14.2.3. By Source
17.14.2.4. By Type
17.14.2.5. By End Use
17.15. India
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2021
17.15.2.1. By Nature
17.15.2.2. By Form
17.15.2.3. By Source
17.15.2.4. By Type
17.15.2.5. By End Use
17.16. ASEAN
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2021
17.16.2.1. By Nature
17.16.2.2. By Form
17.16.2.3. By Source
17.16.2.4. By Type
17.16.2.5. By End Use
17.17. Australia and New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2021
17.17.2.1. By Nature
17.17.2.2. By Form
17.17.2.3. By Source
17.17.2.4. By Type
17.17.2.5. By End Use
17.18. GCC Countries
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2021
17.18.2.1. By Nature
17.18.2.2. By Form
17.18.2.3. By Source
17.18.2.4. By Type
17.18.2.5. By End Use
17.19. Turkey
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2021
17.19.2.1. By Nature
17.19.2.2. By Form
17.19.2.3. By Source
17.19.2.4. By Type
17.19.2.5. By End Use
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2021
17.20.2.1. By Nature
17.20.2.2. By Form
17.20.2.3. By Source
17.20.2.4. By Type
17.20.2.5. By End Use
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Nature
18.3.3. By Form
18.3.4. By Source
18.3.5. By Type
18.3.6. By End Use
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Laboratorio Opoterapico Argentino S.A.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Agri-lab Co-Products Ltd.
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Allergy Research Group LLC
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. American Biologics
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. Pure Natura ehf.
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Fallwood Corporation
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. American Laboratories, Inc.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Food Science Corporation
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. MBi Nutraceuticals
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Food and Beverage Insights
View Reports
Glandular Ingredients Market
